Company Filing History:
Years Active: 2006-2011
Title: The Innovative Contributions of Philip Hopes
Introduction
Philip Hopes is a notable inventor based in Bristol, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on chemical processes that have the potential to impact clinical treatments.
Latest Patents
Among his latest patents is a chemical process identified as Chemical Process 632. This patent describes a method for preparing pharmaceutically active compounds of a specific formula, including novel intermediates. Another important patent involves enzymatic and chemical processes for the preparation of 3-phenyl-2-arylalkylthiopropionic acid derivatives. These derivatives are useful in treating clinical conditions such as lipid disorders and metabolic syndrome.
Career Highlights
Philip Hopes is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to innovative solutions in the pharmaceutical industry.
Collaborations
Throughout his career, Philip has collaborated with esteemed colleagues, including David Brown and John Peter Gilday. These collaborations have further enhanced his research and development efforts.
Conclusion
Philip Hopes is a distinguished inventor whose work in chemical processes has the potential to advance pharmaceutical treatments. His contributions are valuable to the field and reflect his commitment to innovation.